Formulation | Mean size after Lyophi. (nm) | PDI | Zeta potential (mV) | EE (%) |
---|---|---|---|---|
CS-NLC-DiD* |  | ≈100 | ||
TAT-CS-NLC-DiD(*) | ≈100 | |||
Miglyol-NLC | 119.1 ± 18.0 | 0.323 ± 0.039 | 17.4 ± 0.8 | – |
DHAH-NLC | 105.4 ± 25.6 | 0.400 ± 0.032 | 20.9 ± 0.5 | – |
DHAH-NLC-GDNF | 257.1 ± 3.5 | 0.338 ± 0.022 | 18.0 ± 0.4 | 82.01 ± 1.67 |
DHAH-NLC-VEGF | 264.1 ± 16.0 | 0.471 ± 0.076 | 20.5 ± 0.8 | 88.74 ± 0.37 |